CPR offers specialised services supporting drug development for the pharmaceutical and biotechnology industry in the following areas:

• Site independent services for early phase clinical studies.
• GLP bio-analytical services for clinical, pre-clinical and discovery studies.

Based in Adelaide, South Australia, CPR has grown in size and reputation over the past decade and is committed to continuous growth and development through the acquisition of key staff and major infrastructure additions.

Our core clients consist of global pharmaceutical and biotechnology companies, conducting at least some of their drug development program in the Australasian region.

We offer:

• expert and experienced staff
• a strong client focus
• access to leading academic staff as consultants
• state-of-the-art instrumentation (multiple LC/MS/MS capability)
• commitment to pharmaceutical standards such as ICH GCP, GLP and ISO.

CPR provides a quality, cost effective alternative to contract research organisations in the US and Europe. Our client feedback and repeat business confirms that the quality of work performed within CPR is of international standard.

In addition we have vital networks with other Australian service providers in the drug development industry including clinical facilities, GLP pre-clinical in vivo facilities and lead optimisation laboratories.